NEW YORK (GenomeWeb News) – Metabolon has reeled in $6 million in new Series C financing from new investors Syngenta Ventures and Fletcher Spaght Ventures, and from previous investors, bringing the total funding for the round to $12.3 million, the company said today.

The Research triangle Park, NC-based metabolomic diagnostics company also said that it has agreed to expand an earlier research collaboration with Syngenta, and that Syngenta Ventures VP Carol Marina and Fletcher Spaght VP Guy Fish have joined its board of directors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.

Jan
31
Sponsored by
Roche

This webinar highlights the use of single-cell genomics to identify distinct cell types and states associated with enhanced immunity.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.